[{"Assets_0_Q3_USD":1751481000.0,"CommonStockSharesOutstanding_0_Q3_shares":85888000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":303745000.0,"NetIncomeLoss_1_Q3_USD":108837000.0,"NetIncomeLoss_3_Q3_USD":337224000.0,"StockholdersEquity_0_Q3_USD":202418000.0,"EarningsPerShareBasic_1_Q3_USD":1.26,"EarningsPerShareBasic_3_Q3_USD":3.91,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":86198000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":86206000.0,"Ticker":"IDXX","CIK":"874716","name":"IDEXX LABORATORIES INC \/DE","OfficialName":"IDEXX Laboratories Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"42180715521.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"SP500","filed":"20191031"}]